1-5 of 5
Dina Ben-Yehuda
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4024: Phase 1/2a LYM1002 study of ibrutinib (ibr) + nivolumab (nivo): Exome and gene expression profiling (GEP) analyses by histology and responder status

Brendan Hodkinson, Michael Schaffer, Joshua Brody, Wojciech Jurczak, Cecilia Carpio, Dina Ben-Yehuda, Irit Avivi, Rao Saleem, Muhit Özcan, John Alvarez, Rob Ceulemans, Nele Fourneau, Sriram Balasubramanian, Anas Younes
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 4024.
https://doi.org/10.1158/1538-7445.AM2019-4024
Published: 01 July 2019
View article titled, Abstract 4024: Phase 1/2a LYM1002 study of ibrutinib (ibr) + nivolumab (nivo): Exome and gene expression profiling (GEP) analyses by histology and responder status
Journal Articles

The Inhibitor of Apoptosis Protein Livin (ML-IAP) Plays a Dual Role in Tumorigenicity

Ihab Abd-Elrahman, Klilah Hershko, Tzahi Neuman, Boaz Nachmias, Riki Perlman, Dina Ben-Yehuda
Journal: Cancer Research
Cancer Res (2009) 69 (13): 5475–5480.
https://doi.org/10.1158/0008-5472.CAN-09-0424
Published: 01 July 2009
View article titled, The Inhibitor of Apoptosis Protein Livin (ML-IAP) Plays a Dual Role in Tumorigenicity
Open the PDF for The Inhibitor of Apoptosis Protein Livin (ML-IAP) Plays a Dual Role in Tumorigenicity in another window
Journal Articles

Caspase-Mediated Cleavage Converts Livin from an Antiapoptotic to a Proapoptotic Factor: Implications for Drug-Resistant Melanoma

Boaz Nachmias, Yaqoub Ashhab, Vered Bucholtz, Olga Drize, Luna Kadouri, Michal Lotem, Tamar Peretz, Ofer Mandelboim, Dina Ben-Yehuda
Journal: Cancer Research
Cancer Res (2003) 63 (19): 6340–6349.
Published: 14 October 2003
View article titled, Caspase-Mediated Cleavage Converts Livin from an Antiapoptotic to a Proapoptotic Factor: <subtitle>Implications for Drug-Resistant Melanoma</subtitle>
Open the PDF for Caspase-Mediated Cleavage Converts Livin from an Antiapoptotic to a Proapoptotic Factor: <subtitle>Implications for Drug-Resistant Melanoma</subtitle> in another window
Journal Articles

Correspondence re: G. Palumbo et al., The tyrphostin AG17 induces apoptosis and inhibition of cdk2 activity in a lymphoma cell line that overexpresses bcl-2. Cancer Res., 57: 2434–2439, 1997—Reply

Alexander Levitzki, Dina Ben-Yehuda
Journal: Cancer Research
Cancer Res (1997) 57 (24): 5610.
Published: 01 December 1997
View article titled, Correspondence re: G. Palumbo <em>et al.</em>, The tyrphostin AG17 induces apoptosis and inhibition of cdk2 activity in a lymphoma cell line that overexpresses bcl-2. Cancer Res., <em>57:</em> 2434–2439, 1997—Reply
Open the PDF for Correspondence re: G. Palumbo <em>et al.</em>, The tyrphostin AG17 induces apoptosis and inhibition of cdk2 activity in a lymphoma cell line that overexpresses bcl-2. Cancer Res., <em>57:</em> 2434–2439, 1997—Reply in another window
Journal Articles

The Tyrphostin AG17 Induces Apoptosis and Inhibition of cdk2 Activity in a Lymphoma Cell Line That Overexpresses bcl-2

Giuseppe A. Palumbo, Nirit Yarom, Aviv Gazit, Ziv Sandalon, Michal Baniyash, Nurit Kleinberger-Doron, Alexander Levitzki, Dina Ben-Yehuda
Journal: Cancer Research
Cancer Res (1997) 57 (12): 2434–2439.
Published: 01 June 1997
View article titled, The Tyrphostin AG17 Induces Apoptosis and Inhibition of cdk2 Activity in a Lymphoma Cell Line That Overexpresses bcl-2
Open the PDF for The Tyrphostin AG17 Induces Apoptosis and Inhibition of cdk2 Activity in a Lymphoma Cell Line That Overexpresses bcl-2 in another window